by Jan Barbořík | 20. 7. 2022
CLINICAL TRIAL WHO_DC1311 Combination anti-tumour therapy with ex vivo manipulated interleukin-12 producing dendritic cells in paediatric, adolescent and young adult patients with progressive, relapsed or primary metastatic high-risk malignancies KDO_DC1311 is a phase...
by Jan Barbořík | 23. 6. 2022
CLINICAL TRIAL HALF Prospective phase II clinical trial evaluating the efficacy and safety of tyrosine kinase inhibitor discontinuation after prior two-step dose reduction in patients with chronic myeloid leukemia in deep molecular remission The HALF clinical trial is...
by Jan Barbořík | 16. 2. 2022
CLINICAL TRIAL CoVigi CoVigi is a phase IV multicentre post-registration intervention study to monitor long-term safety and efficacy after vaccination against COVID-19.The study was initiated by Masaryk University in collaboration with the University Hospital Brno and...
by Jan Barbořík | 16. 2. 2022
CLINICAL TRIAL SolidAct European DisCoVeRy for Solidarity (EU-SolidAct): a clinical trial with an adaptive platform design for pandemics and emerging infections Within the platform design, the study follows a generic main protocol, to which a drug-specific...
by Jan Barbořík | 10. 2. 2022
CLINICAL TRIALS DISCoVeRy A multicenter, adaptive, randomized study of the safety and efficacy of treatment in hospitalized adult patients with COVID-19. The treatment of COVID-19 is still a major challenge for medical research, so new drugs are being investigated or...
